中国国际金融股份有限公司 关于北京同益中新材料科技股份有限公司 股东向特定机构投资者询价转让股份 相关资格的核查意见 中国国际金融股份有限公司（以下简称"中金公司"）受北京同益中新材料 科技股份有限公司（以下简称"同益中"）股东国家产业投资基金有限责任公司 （以下简称"国家产业投资基金""出让方"）委托，组织实施本次同益中股东 向特定机构投资者询价转让（以下简称"本次询价转让"）。 根据《关于在上海证券交易所设立科创板并试点注册制的实施意见》《科创 板上市公司持续监管办法（试行）》《上海证券交易所科创板股票上市规则》《上 海证券交易所科创板上市公司自律监管指引第 4 号——询价转让和配售》（以下 简称"《询价转让和配售指引》"）等相关规定，中金公司对参与本次询价转让出 让方的相关资格进行了核查。 1 （二）核查情况 1、国家产业投资基金 （1）基本情况 | 企业名称 | 国家产业投资基金有限责任公司 | | | | | --- | --- | --- | --- | --- | | 统一社会信用代码 | 91110108MA01GC0U3L | | | | | 成立日期 | 2018 年 12 月 24 日 ...

Group 1 - The National Industrial Investment Fund plans to transfer 4.2687 million shares of Tongyi Zhong, representing 1.90% of the company's total share capital [1]

Core Viewpoint - The National Industrial Investment Fund, a shareholder with a 9.71% stake, plans to transfer 4.2687 million shares, representing 1.90% of the company's total equity and 19.57% of its own holdings, due to funding needs [1] Group 1 - The share transfer will be conducted through a non-public offering, with the buyer required to be an institutional investor capable of pricing and risk management [1] - The minimum transfer price will not be lower than 70% of the average trading price of the company's stock over several trading days prior to the issuance of the subscription invitation [1] - There are risks associated with the transfer, including potential judicial freezes on shares and changes in market conditions that could prevent the plan from being executed [1]

Core Viewpoint - The announcement indicates that China International Capital Corporation (CICC) has been entrusted by the National Industry Investment Fund to organize the transfer of shares to specific institutional investors [1] Group 1 - CICC received the commission on December 5, 2025, and completed the qualification verification of the transferor by December 10 [1] - The legal representative of the National Industry Investment Fund is Qu Kebo, who holds more than 5% of the shares [1] - The shares to be transferred are pre-IPO shares with no restrictions or prohibitions on transfer, and necessary procedures for the transfer have been fulfilled [1]

Core Viewpoint - Tongyi Zhong plans to invest approximately 198 million yuan to establish a high-performance polyethylene fiber project, aiming to diversify profit growth through applications in various fields such as safety protection, high-end textiles, marine engineering, medical health, and humanoid robots [2] Group 1: Investment and Expansion - The company will utilize self-owned or self-raised funds for the project, which is expected to produce 2,400 tons of ultra-high molecular weight polyethylene fiber annually [2] - In December 2024, the company announced the acquisition of 75.80% of Supermes New Materials Co., Ltd. for 243 million yuan, making it a subsidiary [2] - This acquisition is a strategic move to enter the aramid fiber market, enhancing the company's supply capabilities in the safety protection sector [2] Group 2: Financial Performance - In the first three quarters of 2025, the company achieved operating revenue of 719 million yuan, a significant increase of 68.03% year-on-year, with a net profit attributable to shareholders of 93.03 million yuan, up 14.15% [3] - The company has successfully developed high molecular fiber tendon products for humanoid robots, entering the supplier list of several leading robotics companies [3] Group 3: Technological Advancements - The company has made progress in the robotics sector, overcoming technical challenges related to high molecular tendon ropes, and has developed various end-termination methods with a noticeable increase in order volume [3] - The company is also advancing into the aramid fiber and aramid paper sectors, establishing a second growth curve for its development [3]

Core Viewpoint - The company Tongyi Zhong announced plans to invest approximately 198 million yuan in a project to produce 2,400 tons of ultra-high molecular weight polyethylene fiber annually, aiming to enhance its market competitiveness and diversify its product offerings [1] Group 1 - The project is expected to have a construction period of 10 months [1] - The implementation of the project will be carried out by the company's Xintai branch located in Xintai City, Shandong Province [1]

Industry News - A new polysilicon platform company named Beijing Guanghe Qiancheng Technology Co., Ltd. has been registered with a capital of 3 billion, established on December 9, 2025, in Beijing. The company aims to explore potential strategic cooperation opportunities within the industry, such as technology upgrades and market expansion [25][25]. - The National Retail Innovation Development Conference is being held in Beijing from December 9 to 10. The Deputy Minister of Commerce, Sheng Qiuping, emphasized the need for further improvement in retail layout, supply-demand matching, and online-offline balance, while also encouraging the development of new business models and scenarios to stimulate consumer potential [25][25]. - The State Administration for Market Regulation has approved the release of two mandatory national standards for civil unmanned aerial vehicles, which will take effect on May 1, 2026 [25][25]. - Alibaba has established the Qianwen C-end Business Group, aiming to develop Qianwen into a super app and the primary entry point for users in the AI era [26][26]. - Huawei's 2012 Lab has established a foundational model department focused on advancing base model development and is actively recruiting young research talents with outstanding academic backgrounds [26][26]. - The Ministry of Agriculture and Rural Affairs reported that pork supply in November was sufficient, with prices slightly decreasing. The average daily market volume of pork in Beijing's Xinfadi market was 2,128.8 heads, a 10.57% increase from October and a 7.54% increase year-on-year [26][26]. - The National Development and Reform Commission indicated that the coking coal market shifted from tight to loose in November, with price expectations declining. The coking coal price expectation index fell to below the 50% threshold, indicating weak support for the market [26][26]. Company News - Jiaao Environmental Protection announced that due to false records in the 2022 and 2023 annual reports, the company's stock will be subject to other risk warnings [27][27]. - Huilun Crystal also announced that its 2021 and 2022 annual reports contained false records, leading to similar risk warnings for its stock [27][27]. - Haiguang Information announced the termination of its major asset restructuring with Zhongke Shuguang [28][28]. - Zhongke Shuguang announced the termination of its share swap absorption merger with Haiguang Information and the associated fundraising [29][29]. - Tianyuan Dike announced that its chairman, Chen You, has been placed under detention [30][30]. - Lain Biological announced that its controlling shareholder is planning a change of control and intends to acquire at least 80% of Beijing Jinkangpu's shares, leading to a stock suspension [30][30]. - Shengyi Technology announced an investment of approximately 198 million yuan to build an annual production project of 2,400 tons of ultra-high molecular weight polyethylene fiber, expanding its application value in humanoid robots [30][30]. - HoloWave announced a significant increase in orders for satellite testing systems, primarily from commercial aerospace satellite manufacturers and testing service providers [30][30]. - Longi Green Energy announced the termination of its overseas issuance of global depositary receipts [31][31]. - Zaiseng Technology announced that its controlling shareholder, Guo Mao, plans to transfer 6.04% of the company's shares to Zhongrong Huaxin [31][31]. - Si Rui Pu announced the termination of its plan to acquire shares of Aola, and its stock will resume trading [32][32]. - Fosun Pharma announced that its subsidiary, Yaoyou Pharmaceutical, has signed a licensing agreement with Pfizer [33][33].

Group 1 - Rhein Biotech and Jia Mei Packaging's controlling shareholders are planning changes in company control, with trading suspension starting from December 10, 2025, for Rhein Biotech expected to last no more than 10 trading days and for Jia Mei Packaging no more than 2 trading days [1][2] - Rhein Biotech intends to acquire at least 80% of Beijing Jinkangpu Food Technology Co., Ltd. through a combination of issuing shares and cash payment, which will make Beijing Jinkangpu a subsidiary included in the consolidated financial statements [1] - Jia Mei Packaging's controlling shareholder is also in discussions regarding a potential change in control, with specific transaction details still under negotiation [2] Group 2 - Haiguang Information has terminated its plan to merge with Zhongke Shuguang through a share exchange, as approved in a board meeting on December 9, 2025 [3] - Huatai Medical plans to repurchase shares with a total amount not less than RMB 200 million and not exceeding RMB 250 million, with a repurchase price cap of RMB 315 per share [4] - Songcheng Performing Arts and Jingu Co., Ltd. also announced share repurchase plans, with Songcheng aiming for a total of RMB 100 million to RMB 200 million and Jingu targeting RMB 30 million to RMB 60 million [4] Group 3 - Xiamen Airport is planning to acquire 100% of the shares of Zhaoxiang Technology, a wholly-owned subsidiary of its controlling shareholder, Xiamen Xiangye Group [5] - Borui Communication intends to acquire 51% of Meijing Technology from related parties for a total price of RMB 66.49 million [6] - Gu Ao Technology's actual controller is planning a change in control, with trading suspension starting from December 8, 2025, and expected to last no more than 3 trading days [6] Group 4 - ST Kevin's application to revoke the risk warning on its stock has been approved, with trading suspension for one day on December 10, 2025, and resuming trading on December 11, 2025 [6] - Huailun Crystal's stock will be suspended for one day starting December 10, 2025, due to false disclosures in its annual reports for 2021 and 2022 [7] - The stock of Jia Ao Environmental Protection will also be suspended for one day on December 10, 2025, due to an administrative penalty notice received from the regulatory authority [12] Group 5 - The company Yongmota plans to invest approximately RMB 400 million in a new project for magnesium-aluminum alloy components for the automotive and robotics industries [20] - ST Ningke is executing a capital reserve transfer plan to increase its share capital, with a total share increase from 684.88 million to 1.62 billion shares [21] - Yingpais plans to increase its shareholding through a combination of bank loans and self-funding, with a total investment of no less than RMB 60 million and no more than RMB 120 million [22]

Group 1 - Wanma Technology has been pre-awarded a total of 59.9434 million yuan for multiple State Grid projects, which accounts for 14.49% of its latest audited main business revenue [1] - Tianen Kang's subsidiary received a drug registration certificate for Methimazole tablets, a medication used for hyperthyroidism [2] - Taijing Technology invested 10 million yuan to establish a special fund focused on high-speed network communication chips [3] Group 2 - Youyou Foods plans to use 10 million yuan of its own funds to purchase principal-protected financial products with an expected annual yield of 0.5%-5.0% [4] - Yangfan New Materials announced the release of detention measures against its controlling shareholder, allowing him to resume his duties [5] - Xianju Pharmaceutical received approval for a supplementary application for Nicardipine injection, a calcium channel blocker used for acute hypertension [6] Group 3 - Jingu Co. plans to repurchase shares worth 30-60 million yuan for employee stock ownership plans or equity incentives [7] - Double Tower Foods' Thai subsidiary has completed the construction of its production line and is in the initial production phase [8] - Tongyi Zhong intends to invest approximately 198 million yuan in a project for the industrialization of ultra-high molecular weight polyethylene fibers [9][10] Group 4 - Zhangyue Technology received a dividend of 4.99 million yuan from its stake in Dianzhong Technology, which represents 10.12% of its audited net profit for 2024 [11] - Sihua Electronics announced the resignation of its general manager due to job transfer, with the current manager continuing until a new one is appointed [12] - Jiutian Pharmaceutical's new drug JMHT06 has received approval for clinical trials for acute gouty arthritis [13] Group 5 - Anlian Ruishi has established a joint venture for embodied intelligent robots with a registered capital of 20 million yuan [14] - Kelin Electric's application for a private placement has been accepted by the Shanghai Stock Exchange [15] - Guoyao Modern's subsidiary has received approval for the listing of Agomelatine raw materials, used in antidepressant synthesis [16] Group 6 - Xintiandi's application for the listing of Ferrous Fumarate raw materials has been approved, which is used for treating iron deficiency anemia [17] - ST Weihai, as the leading party, won a bid for a smart agriculture project worth 652 million yuan, accounting for 26.27% of its 2024 audited revenue [18] - Tian Youwei plans to purchase 100% of Krämer Automotive Systems for 1 million euros [19] Group 7 - Guangdong Yuedian A's subsidiary has successfully put into operation the third unit of its Dapu Power Plant project [20] - China Life's total premium exceeded 700 billion yuan as of November 30, 2025 [21] - Shoukai Co. achieved a total signed amount of 15.988 billion yuan in the first 11 months of 2025 [22] Group 8 - Kehua Bio's subsidiary has obtained a medical device registration certificate for an automatic chemiluminescence immunoassay analyzer [23] - Chengyi Pharmaceutical received a drug registration certificate for Torasemide tablets, which have passed the consistency evaluation [24] - Chongqing Construction won a bid for a municipal engineering project worth approximately 1.714 billion yuan [25] Group 9 - Hanjian Heshan signed a procurement contract for pipes worth 388 million yuan [26] - Jiuzhou Pharmaceutical plans to use up to 1 billion yuan of idle raised funds for cash management [27] - Xinwufeng reported an 80.97% year-on-year increase in pig sales in November 2025 [28] Group 10 - Luoniushan reported a 13.57% year-on-year increase in pig sales revenue in November 2025 [29] - Fushilai received a drug registration certificate for Alpha-Lipoic Acid tablets, used for diabetic neuropathy [30] - Dizhe Pharmaceutical presented research data on two innovative drugs at the 67th American Society of Hematology conference [31] - David Medical's subsidiary received two medical device registration certificates for single-use gastric tubes and electronic ureteral endoscope catheters [32]

证券代码：688722 证券简称：同益中 公告编号：2025-043 北京同益中新材料科技股份有限公司 关于对外投资的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 北京同益中新材料科技股份有限公司（以下简称"公司"）结合行业发展趋 势及公司战略规划，为提前布局细分市场，进一步满足下游市场的需求，丰富公 司产品类别，提升产品市场竞争力，公司拟以自有资金或自筹资金约人民币 1.98 亿元建设年产 2400 吨超高分子量聚乙烯纤维产业化项目（以下简称"本项目"）。 投资标的名称：年产 2400 吨超高分子量聚乙烯纤维产业化项目 根据《上海证券交易所科创板股票上市规则》等有关法律、法规、规范性文 件的相关规定，本次投资事项不构成关联交易，亦不构成《上市公司重大资产重 组管理办法》规定的重大资产重组情形。 投资金额：预计项目总投资约 1.98 亿元（最终投资金额以项目建设实际 投入为准） 本次投资事项已经公司第三届董事会第七次会议审议通过，无需提交股东会 审议。董事会授权公司管理层负责办理此项投资的所有后续事 ...